Colinak NH, emulsja do wstrzykiwań dla gołębi
Colinak NH, emulsja do wstrzykiwań dla gołębi
Not authorised
- Newcastle disease virus, strain M/93, Inactivated
- Pigeon herpesvirus, strain V-5443, Inactivated
Product identification
Medicine name:
Colinak NH, emulsja do wstrzykiwań dla gołębi
Active substance:
- Newcastle disease virus, strain M/93, Inactivated
- Pigeon herpesvirus, strain V-5443, Inactivated
Target species:
-
Pigeon
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Newcastle disease virus, strain M/93, Inactivated100000000.00/50% Embryo Infective Dose0.30millilitre(s)
-
Pigeon herpesvirus, strain V-5443, Inactivated10000.00/50% tissue culture infectious dose0.30millilitre(s)
Pharmaceutical form:
-
Emulsion for injection/infusion
Withdrawal period by route of administration:
-
Subcutaneous use
-
Pigeon
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01EA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Pulawy Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Mevak a.s.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1710
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 15/11/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 15/11/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 15/11/2024